Antibiotic Resistance News and Research

RSS

Norwegian blood samples reveal E. coli variants that are resistant to several antibiotics

One out of ten E. coli samples contained variants that are resistant to several kinds of antibiotics, a new analysis on Norwegian blood samples revealed. The proportion of multi-resistant E. coli bacteria doubled from 2002-2009 to 2010-2017.

27 May 2021

New mathematical model predicts how bacterial mutations influence the success of antibiotic treatments

Scientists have developed a mathematical model that predicts how the number and effects of bacterial mutations leading to drug resistance will influence the success of antibiotic treatments.

19 May 2021

Genomic study tracks the rise of multidrug resistant E.coli

Antibiotic resistance in E.coli has been steadily increasing since the early 2000s despite attempts to control it, a new study suggests.

17 May 2021

What can ancient feces tell us about the evolution of the human gut microbiome?

Researchers at the Section on Pathophysiology and Molecular Pharmacology, Joslin Diabetes Center in Boston, Massachusetts, analyzed microbial DNA found in indigenous human paleofeces (desiccated excrement) from dry caves in northern Mexico and Utah. They found that the ancient human gut microbiome is similar to those of modern-day people from non-industrialized populations.

14 May 2021

Ancient people had far different microorganisms in their guts than modern humans

Only an anthropologist would treasure millennia-old human feces found in dry caves. Just ask Dr. Meradeth Snow, a University of Montana researcher and co-chair of UM's Department of Anthropology.

13 May 2021

Study: Organic-certified meats less likely to be contaminated with pathogenic bacteria

Meat that is certified organic by the U.S. Department of Agriculture is less likely to be contaminated with bacteria that can sicken people, including dangerous, multidrug-resistant organisms, compared to conventionally produced meat, according to a study from researchers at the Johns Hopkins Bloomberg School of Public Health.

12 May 2021

Scientists find dramatic differences between ancient gut microbiomes and modern microbes

Scientists are rapidly gathering evidence that variants of gut microbiomes, the collections of bacteria and other microbes in our digestive systems, may play harmful roles in diabetes and other diseases.

12 May 2021

Inappropriate antibiotic prescribing for upper respiratory tract infections contributes to antibiotic resistance

Inappropriate antibiotic prescribing for upper respiratory tract infections contributes to antibiotic resistance, making some bacterial infections difficult to treat.

12 May 2021

Primary care should adopt new approach to make meaningful gains in cardiovascular disease care

In order to make meaningful gains in cardiovascular disease care, primary care medical practices should adopt a set of care improvements specific to their practice size and type, according to a new study from the national primary care quality improvement initiative EvidenceNOW.

12 May 2021

Specially designed hydrogel offers great hope for combating antibiotic-resistant bacteria

Researchers at Chalmers University of Technology, Sweden, have developed a new material that prevents infections in wounds - a specially designed hydrogel, that works against all types of bacteria, including antibiotic-resistant ones.

11 May 2021

Study discovers harmful inflammatory protein in patients with symptomatic tuberculosis

A pioneering study by UCL scientists has discovered the presence of a harmful inflammatory protein in patients with symptomatic tuberculosis (TB).

10 May 2021

New "molecular tweezers" can help combat antibiotic-resistant bacteria

Researchers from Ben-Gurion University (BGU), together with American and German colleagues, have developed new "molecular tweezers" to combat antibiotic-resistant bacteria. Their recently announced findings were published in Cell Chemical Biology.

10 May 2021

Telemedicine is a tool — not a replacement for your doctor’s touch

Earlier in the pandemic it was vital to see doctors over platforms like Zoom or FaceTime when in-person appointments posed risks of coronavirus exposure. Insurers were forced — often for the first time — to reimburse for all sorts of virtual medical visits and generally at the same price as in-person consultations.

6 May 2021

Scientists discover fundamental regulation mechanism of proteins

Proteins perform a vast array of functions in the cell of every living organism with critical roles in almost every biological process.

5 May 2021

New testing technology can accurately differentiate between viral and bacterial infections

When patients complain of coughing, runny nose, sneezing and fever, doctors are often stumped because they have no fundamental tool to identify the source of the respiratory symptoms and guide appropriate treatments.

4 May 2021

Designing effective multidrug-resistant-TB treatments based on DNA sequencing

Globally, tuberculosis is the most common bacterial infectious disease leading to death. The pathogen causing tuberculosis, Mycobacterium tuberculosis, has a number of peculiarities. One is that it is growing very slowly.

3 May 2021

Texas A&M AgriLife receives grant to support research on bacteriophage therapy

The National Institute of Allergy and Infectious Diseases, NIAID, part of the National Institutes of Health, NIH, has awarded $2.5 million in grants to support research on bacteriophage therapy, and Texas A&M AgriLife Research is among the grant recipients.

29 Apr 2021

Nanobodies may be the key to blocking tick-borne bacterial infection

Tiny molecules called nanobodies, which can be designed to mimic antibody structures and functions, may be the key to blocking a tick-borne bacterial infection that remains out of reach of almost all antibiotics, new research suggests.

28 Apr 2021

Georgia State professor receives $2.3 million federal grant to study inflammation in infectious diseases

Dr. Jian-Dong Li, professor and director of the Institute for Biomedical Sciences at Georgia State University, has received a five-year, $2.3 million federal grant to study how overactive inflammatory response is caused in infectious diseases and to further develop novel anti-inflammatory therapeutics.

21 Apr 2021

Phico Therapeutics awarded up to $18.2 million USD (c.£13.2 million GBP) CARB-X funding to advance SASPject antibacterial therapy through Phase 1 clinical trials

Phico Therapeutics has been awarded a grant of up to $18.2 million USD to tackle the global rising threat of drug-resistant bacteria.

From Phico Therapeutics 19 Apr 2021

Antibiotic Resistance News and Research

Norwegian blood samples reveal E. coli variants that are resistant to several antibiotics

New mathematical model predicts how bacterial mutations influence the success of antibiotic treatments

Genomic study tracks the rise of multidrug resistant E.coli

What can ancient feces tell us about the evolution of the human gut microbiome?

Ancient people had far different microorganisms in their guts than modern humans

Study: Organic-certified meats less likely to be contaminated with pathogenic bacteria

Scientists find dramatic differences between ancient gut microbiomes and modern microbes

Inappropriate antibiotic prescribing for upper respiratory tract infections contributes to antibiotic resistance

Primary care should adopt new approach to make meaningful gains in cardiovascular disease care

Specially designed hydrogel offers great hope for combating antibiotic-resistant bacteria

Study discovers harmful inflammatory protein in patients with symptomatic tuberculosis

New "molecular tweezers" can help combat antibiotic-resistant bacteria

Telemedicine is a tool — not a replacement for your doctor’s touch

Scientists discover fundamental regulation mechanism of proteins

New testing technology can accurately differentiate between viral and bacterial infections

Designing effective multidrug-resistant-TB treatments based on DNA sequencing

Texas A&M AgriLife receives grant to support research on bacteriophage therapy

Nanobodies may be the key to blocking tick-borne bacterial infection

Georgia State professor receives $2.3 million federal grant to study inflammation in infectious diseases

Phico Therapeutics awarded up to $18.2 million USD (c.£13.2 million GBP) CARB-X funding to advance SASPject antibacterial therapy through Phase 1 clinical trials

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo